Somerville Kurt F Novartis Ag Transaction History
Somerville Kurt F
- $579 Million
- Q2 2025
A detailed history of Somerville Kurt F transactions in Novartis Ag stock. As of the latest transaction made, Somerville Kurt F holds 14,323 shares of NVS stock, worth $1.67 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
14,323
Previous 16,093
11.0%
Holding current value
$1.67 Million
Previous $1.79 Million
3.4%
% of portfolio
0.3%
Previous 0.32%
Shares
32 transactions
Others Institutions Holding NVS
# of Institutions
1,545Shares Held
141MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.38 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.21 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$823 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$789 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...